MGI beats Street

MOGN reported second quarter EPS of $0.11, beating by $0.06 the Street's $0.05 estimate and up from a loss per share of $0.14 in the second quarter of 2003. Second quarter sales of Aloxi palonosetron to prevent chemotherapy-induced nausea and vomiting were $37.1 million. The drug was launched in September 2003. ...